#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Henoch-Schonlein purpura nephritis Choroid melanoma Lymphangiosarcoma Dementia with Lewy bodies Waldenstrom's macroglobulinaemia recurrent Haemophilia A with anti factor VIII Niemann-Pick disease Giant cell tumour of tendon sheath Obesity Adenocarcinoma gastric Anaplastic large cell lymphoma T- and null-cell types Short stature Fusarium infection Antithrombin III deficiency Ovarian cancer More trials…

    Learn about Rare Diseases

    Combined immunodeficiency Pleural mesothelioma malignant – Basic Information Hyperoxaluria – Life with Disease Rhabdomyosarcoma – Basic Information Methylmalonic acidaemia – Basic Information Retinitis pigmentosa – Life with Disease Phenylketonuria – Trials in Disease Angiosarcoma metastatic – Basic Information Behcet’s syndrome – Treatment Haemophilia B without inhibitors – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    YOHIMBINE HYDROCHLORIDE Other Blood Products Gskvx000000014593 Iohexol Tramadol M-(18F)-Fluorobenzylguanidine Sibeprenlimab Melphalan Flufenamide Minocycline Piromelatine Camlipixant Zelicapavir Cdr132L Sodium Eptacog Beta (Activated) Ecoo15 Atezolizumab Selatogrel Ucart22 Jnj-64042056 Fentanyl Citrate More therapies…

    Learn about Your Condition

    Muscle spasticity Cartilage injury Pathogen resistance Thymic carcinoma Adenocarcinoma of colon Adrenal insufficiency Herpes simplex Spinal pain Adrenogenital syndrome Angiosarcoma recurrent Postpartum haemorrhage Deafness bilateral Hepatobiliary cancer Essential thrombocythaemia Alcohol abuse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Clonazepam
    • Lenograstim
    • Etoposide Phosphate
    Germany

  • Study on Rituximab Treatment for Children with Complicated Steroid-Sensitive Nephrotic Syndrome

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Rituximab
    Italy

  • Study on Rivaroxaban for Stabilizing Carotid Artery Plaques in Patients with Stable Peripheral Artery Disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Carotid arteriosclerosis
    Investigated Drugs:
    • Rivaroxaban
    Denmark

  • Study of Rituximab compared to placebo in patients with anti-MAG neuropathy who are likely to respond well to treatment

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Anti-myelin-associated glycoprotein associated polyneuropathy
    Investigated Drugs:
    • Rituximab
    • Sodium Chloride
    France

  • Study on Colchicine for Treating Patients with Inflammatory Cardiomyopathy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Colchicine
    Italy

  • Study on the Effectiveness of Valganciclovir for Patients with Glioblastoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Valganciclovir
    Norway Sweden
Previous Page
1 … 905 906 907 908 909 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!